Over ons

We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function enhanced antibodies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO®) antibody medicines. We are united by our core values: a passion for innovation, determination, integrity, and working as one team and respecting each other. When you work at Genmab you'll be part of a warm, fun, dynamic community seeking out and embracing the opportunity to build new and bold futures within a rapidly growing biotechnology company. Genmab is a place where you can be authentically you; you are empowered to innovate, build solutions and execute; you feel cared for and supported. In its totality, this makes working at Genmab an extra[not]ordinaryTM experience. Established in 1999, we are headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com. Disclaimer: http://bit.ly/GENDisclaimer

Website
http://www.genmab.com
Branche
Biotechnologisch onderzoek
Bedrijfsgrootte
1.001 - 5.000 medewerkers
Hoofdkantoor
Copenhagen V
Type
Naamloze vennootschap

Locaties

Medewerkers van Genmab

Updates

Vergelijkbare pagina’s

Door vacatures bladeren

Financiering

Genmab 5 rondes in totaal

Laatste ronde

Vermogen na beursgang

US$ 134.000.000,00

Bekijk meer informatie over Crunchbase